Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
Chatbot Bills Near Passage in CA A pair of bills aimed at protecting minors from harm by chatbots are nearing passage in California. Of the two, tech groups favor SB 243 , which would allow citizens...
NM Gov Calls Special Session to Bolster Safety Net New Mexico Gov. Michelle Lujan Grisham (D) announced a special session in October to bolster safety net programs in response to the federal spending...
Political “debanking,” the practice of banks restricting or closing customers’ accounts for political or religious reasons, has once again become a hot topic , thanks to President Donald...
CO Lawmakers Tweak Last Year’s First-In-Nation AI Law In a special session that began last week, Colorado Senate Majority Leader Robert Rodriguez (D) introduced legislation ( SB 4 a ) that would...
States Seek Ways to Replace Expiring Federal Health Subsidies Policymakers in California, Colorado, Maryland and other states are considering ways to backfill pandemic-era federal health insurance subsidies...
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
Policymakers in California, Colorado, Maryland and other states are considering ways to backfill pandemic-era federal health insurance subsidies expiring at the end of this year. Since states don’t have the resources to replace all that federal funding, health insurance premiums are likely to soar next year. (PLURIBUS NEWS)
New Hampshire Gov. Kelly Ayotte (R) signed a bill (HB 701) allowing patients to try experimental health treatments for rare diseases. The measure expands on a law enacted by the state in 2016. (WMUR)
—Compiled by SNCJ Managing Editor KOREY CLARK
Visit our webpage to connect with a LexisNexis® State Net® representative and learn how the State Net legislative and regulatory tracking service can help you identify, track, analyze and report on relevant legislative and regulatory developments.